SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Want to cut your energy bills? Here’s how five experts are doing it 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes 
BURLINGTON, Mass., March 08, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at 29th Annual ROTH Conference on Tuesday, March 14, 2017 at the Ritz-Carlton, Laguna Niguel, CA.
The Company is scheduled to present at 9:00 a.m. PDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]
